Walleye Trading’s Ibere Pharmaceuticals IBER Stock Holding History

Walleye Trading’s Portfolio IBER Stock Details IBER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-80,000	Closed	-$807K	–	5654
2022 Q4	$807K	Hold	80,000	–	–	﹤0.01%	2411
2022 Q3	$793K	Hold	80,000	–	–	﹤0.01%	2452
2022 Q2	$785K	Hold	80,000	–	–	﹤0.01%	2471
2022 Q1	$785K	Hold	80,000	–	–	﹤0.01%	2458
2021 Q4	$778K	Buy	+80,000	New	+$778K	﹤0.01%	2480

Walleye Trading's IBER Position: Q1 2023 in Review

Walleye Trading sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 80,000 shares — an estimated $807K sold.

Walleye Trading first reported a position in IBER in Q4 2021 and held it in 5 quarters. The position peaked at $807K in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

Walleye Trading reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Walleye Trading sold 80,000 Ibere Pharmaceuticals shares in Q1 2023, an estimated $807K.
Walleye Trading first reported a position in Ibere Pharmaceuticals in Q4 2021 and held it in 5 quarters.
Walleye Trading's Ibere Pharmaceuticals position peaked at $807K in Q4 2022.
0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.